Vaccine Maker Also Reported Q1 Earnings That Missed Estimates Friday Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the ...
Moderna laid out three priorities at its Investor Day. The first was to increase the usage of its Spikevax and mRESVIA vaccines. Spikevax is the company's current COVID vaccine, which was recently ...
Colin is a Senior Writer of tech and financial news. He has more than three years of experience writing, editing, proofreading, and fact-checking content. He received his M.A. in journalism from The ...
Moderna Therapeutics (NASDAQ: MRNA) was once the darling of the healthcare space for investors. The company emerged as one of the biggest names of the COVID-19 pandemic with its vaccine. While COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results